Mi Compañero de Viaje adds a decade of donations in the fight against childhood and adolescent cancer research

L’associació, un any més, ha mostrat el seu compromís amb la recerca oncològica amb un donatiu de 19.197 € al grup de recerca de Càncer i Malalties Hematològiques Infantils del VHIR.

14/01/2025

The association Mi Compañero de Viaje, led by Andrea, Sara, and Marta, offers support to young people with cancer and works to raise awareness about the disease and raise funds for oncological research. Mi Compañero de Viaje has been collaborating with the Vall d'Hebron Research Institute (VHIR) since 2015 with a total of €154,778 allocated to childhood and adolescent cancer research.

Andrea and Mireia gave shape to this initiative, as they themselves had to overcome cancer. This was the reason that led them to create this association: the will to offer any young person who found themselves in the same situation they did support and the ability to share their concerns, among others. They managed to make it a reality and offer the help they would have liked to receive during their oncological process. Since then, Mi Compañero de Viaje has raised funds to finance research projects at VHIR.

"More than 10 years ago, the entity has been committed to childhood cancer research alongside Vall d'Hebron. Everything we have been able to contribute up to today is the result of the solidarity of many people and entities who have believed in the cause and have wanted to contribute their grain of sand. We are very grateful to each of them, as well as to Dr. Roma and his entire team for continuing to fight day after day to advance the research of this disease," says Andrea Martí, president and co-founder of Mi Compañero de Viaje.

This year, they made a donation of €19,197, aimed at the project led by Dr. Josep Roma, principal investigator of the Cancer and Hematological Diseases Group for Children. The team is working on the preclinical development of a new treatment to improve survival rates and quality of life for patients with rhabdomyosarcoma, a highly malignant type of childhood tumor.

Mi Compañero de Viaje has been a constant help in the path of our research to develop new therapies to fight childhood cancer and sarcomas in particular. It is an association that has been very active and has helped us a lot to carry out our research during all these years,” explains Dr. Roma. “I thank them for their collaboration, both to its members and the extensive network of collaborators who have allowed us to get this far,” he adds.

Advances in the research group

The experience of the group in recent years has allowed them to identify new molecular targets very close to the clinical phase. At this stage, collaborations have been consolidated with the biotechnology industry for the development of small molecules that inhibit pro-oncogenic processes such as invasion or proliferation. The goal is to provide patients with innovative and more specific therapies based on biological evidence.
 

Share it:

Related news

Subscribe to our newsletters and be a part of Vall d'Hebron Campus

The acceptance of these terms implies that you give your consent to the processing of your personal data for the provision of the services you request through this portal and, if applicable, to carry out the necessary procedures with the administrations or public entities involved in the processing. You may exercise the mentioned rights by writing to web@vallhebron.cat, clearly indicating in the subject line “Exercise of LOPD rights”.
Responsible entity: Vall d’Hebron University Hospital (Catalan Institute of Health).
Purpose: Subscription to the Vall d’Hebron Barcelona Hospital Campus newsletter, where you will receive news, activities, and relevant information.
Legal basis: Consent of the data subject.
Data sharing: If applicable, with VHIR. No other data transfers are foreseen. No international transfer of personal data is foreseen.
Rights: Access, rectification, deletion, and data portability, as well as restriction and objection to its processing. The user may revoke their consent at any time.
Source: The data subject.
Additional information: Additional information can be found at https://hospital.vallhebron.com/es/politica-de-proteccion-de-datos.